Home > Healthcare > Medical Devices > Diagnostic Devices > Liquid Biopsy Market

Liquid Biopsy Market Share

Report ID: GMI3775
Published Date: Nov 2021
Report Format: PDF

Download Free Sample

Liquid Biopsy Market Share

Major companies operating in the liquid biopsy market are:

F. Hoffmann-La Roche Ltd
BIOCEPT Inc
QIAGEN
Myriad Genetics, Inc
Guardant Health, Inc
Illumina, Inc
Lucence health Inc
EPIGENOMICS AG.

These participants are adopting various growth strategies such as collaborations, acquisitions & mergers, partnerships, and product launches to gain competitive edge over others.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Market size of liquid biopsy surpassed USD 1.2 billion in 2020 and is expected to expand at a CAGR of 29.7% from 2021 to 2027 with increasing awareness regarding the causes and diagnosis of cancer.

The kits & reagents accounted for over 50% of the revenue share in 2020 and will grow with soaring adoption of liquid biopsy in research institutes and reference laboratories.

The lung cancer is poised to exhibit a growth rate of 29.7% up to 2027 owing to the growing adoption of unhealthy lifestyle, comprising tobacco consumption and smoking, and a subsequent increase in the incidence rate.

North America market size recorded 31% of the global industry revenue in 2020 and will rise with the availability of highly advanced infrastructure and faster adoption of advanced methods.

Major players across the industry comprise Guardant Health, Inc., F. Hoffmann-La Roche Ltd., Lucence Health Inc., Genetics, Inc., BIOCEPT, Inc., and others.